iSpecimen Inc.
Services-Commercial Physical & Biological Research · WOBURN · MA
Moderate confidence (50%)
Updated Oct 19, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: iSpecimen Inc. received a delisting notice from its exchange (Sep 8, 2026)
Timeline
Every material event, newest first. History is never overwritten.
iSpecimen Inc. received a delisting notice from its exchange
Sep 8, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 8, 2026, iSpecimen Inc. (the Company ) received a letter dated September 8, 2026 (the Deficiency Letter ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it had been granted an extension of time to regain compliance with Nasdaq Listing Rule 5550(b) (the Rule ). On May 29, 2026, Nasdaq first notified the Company that it did not comply with the Rule. The Rule requires listed companies to maintain a minimum of…”
iSpecimen Inc. received a delisting notice from its exchange
May 29, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 29, 2026, iSpecimen Inc. (the Company ) received a letter (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1) (the Rule ), which requires a minimum of $2,500,000 in stockholders equity for continued listing on the Nasdaq Capital Market (the Capital Market ). As reported in the Company s Quarterly Report on Form 10-Q for the period ended March 31,…”
iSpecimen Inc. received a delisting notice from its exchange
May 8, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed on a Current Report on Form 8-K filed with the Securities and Exchange Commission on November 21, 2025, on November 19, 2025, the Company received a written notice from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the closing bid price of the Company s common stock had been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Services-Commercial Physical & Biological Research
- Subindustry
- —
- Listing
- SEC lists the ticker ISPC on Nasdaq.
- SEC CIK
- 0001558569
- Website
- —
- —
- Headquarters
- WOBURN, MA
- Also known as
- —
- Legal entities
- iSpecimen Inc.
Sources
Every material source used to build this profile.
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 8, 2026, iSpecimen Inc. (the Company ) received a letter dated September 8, 2026 (the Deficiency Letter ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it had been granted an extension of time to regain compliance with Nasdaq Listing Rule 5550(b) (the Rule ). On May 29, 2026, Nasdaq first notified the Company that it did not comply with the Rule. The Rule requires listed companies to maintain a minimum of…
View source recordSEC Company Submissions (TIER 1 · UNVERIFIED)
iSpecimen Inc. — Services-Commercial Physical & Biological Research (SIC 8731) — WOBURN, MA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 29, 2026, iSpecimen Inc. (the Company ) received a letter (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1) (the Rule ), which requires a minimum of $2,500,000 in stockholders equity for continued listing on the Nasdaq Capital Market (the Capital Market ). As reported in the Company s Quarterly Report on Form 10-Q for the period ended March 31,…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed on a Current Report on Form 8-K filed with the Securities and Exchange Commission on November 21, 2025, on November 19, 2025, the Company received a written notice from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the closing bid price of the Company s common stock had been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:39 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.